| Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 C Hiemke, N Bergemann, HW Clement, A Conca, J Deckert, K Domschke, ... Pharmacopsychiatry 51 (01/02), 9-62, 2018 | 1261 | 2018 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 875 | 2022 |
| Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder J Deckert, M Catalano, YV Syagailo, M Bosi, O Okladnova, D Di Bella, ... Human molecular genetics 8 (4), 621-624, 1999 | 751 | 1999 |
| International meta-analysis of PTSD genome-wide association studies identifies sex-and ancestry-specific genetic risk loci CM Nievergelt, AX Maihofer, T Klengel, EG Atkinson, CY Chen, KW Choi, ... Nature communications 10 (1), 4558, 2019 | 449 | 2019 |
| Association between A2a receptor gene polymorphisms and caffeine-induced anxiety K Alsene, J Deckert, P Sand, H de Wit Neuropsychopharmacology 28 (9), 1694-1702, 2003 | 419 | 2003 |
| Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety E Childs, C Hohoff, J Deckert, K Xu, J Badner, H De Wit Neuropsychopharmacology 33 (12), 2791-2800, 2008 | 307 | 2008 |
| Predictors of elevational biodiversity gradients change from single taxa to the multi-taxa community level MK Peters, A Hemp, T Appelhans, C Behler, A Classen, F Detsch, ... Nature communications 7 (1), 13736, 2016 | 296 | 2016 |
| Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. AT Gloster, HU Wittchen, F Einsle, T Lang, S Helbig-Lang, T Fydrich, ... Journal of consulting and clinical psychology 79 (3), 406, 2011 | 278 | 2011 |
| Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial CE Angermann, G Gelbrich, S Störk, H Gunold, F Edelmann, R Wachter, ... Jama 315 (24), 2683-2693, 2016 | 274 | 2016 |
| Reduced amygdala–prefrontal coupling in major depression: association with MAOA genotype and illness severity U Dannlowski, P Ohrmann, C Konrad, K Domschke, J Bauer, H Kugel, ... International Journal of Neuropsychopharmacology 12 (1), 11-22, 2009 | 249 | 2009 |
| Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption PJ Rogers, C Hohoff, SV Heatherley, EL Mullings, PJ Maxfield, ... Neuropsychopharmacology 35 (9), 1973-1983, 2010 | 247 | 2010 |
| Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of … J Deckert, MM Nöthen, P Franke, C Delmo, J Fritze, M Knapp, W Maier, ... Molecular psychiatry 3 (1), 81-85, 1998 | 220 | 1998 |
| Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder T Dresler, A Guhn, SV Tupak, AC Ehlis, MJ Herrmann, AJ Fallgatter, ... Journal of neural transmission 120, 3-29, 2013 | 216 | 2013 |
| Neuropeptide S receptor gene—converging evidence for a role in panic disorder K Domschke, A Reif, H Weber, J Richter, C Hohoff, P Ohrmann, ... Molecular psychiatry 16 (9), 938-948, 2011 | 216 | 2011 |
| Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression K Domschke, U Dannlowski, P Ohrmann, B Lawford, J Bauer, H Kugel, ... European Neuropsychopharmacology 18 (10), 751-759, 2008 | 215 | 2008 |
| Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women K Domschke, CM Freitag, G Kuhlenbäumer, A Schirmacher, P Sand, ... International Journal of Neuropsychopharmacology 7 (2), 183-188, 2004 | 208 | 2004 |
| Meta‐analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity K Domschke, J Deckert, MC O'donovan, SJ Glatt American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144 …, 2007 | 206 | 2007 |
| 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression U Dannlowski, P Ohrmann, J Bauer, J Deckert, C Hohoff, H Kugel, V Arolt, ... Neuropsychopharmacology 33 (2), 418-424, 2008 | 198 | 2008 |
| Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety C Ziegler, U Dannlowski, D Bräuer, S Stevens, I Laeger, H Wittmann, ... Neuropsychopharmacology 40 (6), 1528-1538, 2015 | 196 | 2015 |
| MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy C Ziegler, J Richter, M Mahr, A Gajewska, MA Schiele, A Gehrmann, ... Translational Psychiatry 6 (4), e773-e773, 2016 | 186 | 2016 |
